Ortho Clinical Diagnostics Holdings plc provides in-vitro diagnostics solutions to the clinical laboratory and transfusion medicine communities worldwide. The company offers automated instruments; and assays, reagents, and other consumables that are used by these instruments to generate test results. Its solutions include clinical chemistry and immunoassay instruments and tests to detect and monitor disease progression across a spectrum of therapeutic areas, including COVID-19 antibody and antigen tests; and immunohematology instruments and tests for blood typing to ensure patient-donor compatibility in blood transfusions, as well as donor screening instruments and tests for blood and plasma screening for infectious diseases. The company is also involved in the provision of contract manufacturing and orthocare services. Its products are used in hospitals, laboratories, clinics, blood banks, and donor centers. Ortho Clinical Diagnostics Holdings plc was founded in 1939 and is headquartered in Raritan, New Jersey.
Is OCDX a good dividend investment in 2026?
OCDX offers a 11.34% forward yield with a 50% payout ratio. Strand Safety Score: 85/100 (Very Safe). The 5-year dividend CAGR of 0% is modest — investors should weigh current income against growth alternatives.
OCDX DRIP calculator — what's the difference?
With DRIP on a $10,000 investment over 10 years, your OCDX portfolio grows to $36.9K vs $27.0K without reinvestment. This is the compound interest effect in action.
OCDX dividend growth history & forecast
OCDX has grown its dividend by 0% over the last year and 0% annually over 5 years. At this pace, an investor who holds for 10+ years will see their yield on cost grow substantially above the current 11.34%.
Strand Safety Score™ is proprietary to DividendFlow. Inputs: FCF, Debt/EBITDA, Net Income from SEC filings via FMP. Not financial advice. N/A for ETFs, pre-revenue companies, and tickers without income statements.
🌍 OCDX Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold OCDX.
Gross yield
11.34%
Tax rate
15.00%
After-tax yield
9.64%
Real yield (−CPI)
6.84%
Account/Country
Tax Rate
After-tax Yield
Real Yield
$10K Annual Income
🇺🇸 Roth IRA / 401k
0%
11.34%
8.54%
$1,134 / yr
🇺🇸 US Taxable (15%) ✓
15%
9.64%
6.84%
$964 / yr
🇺🇸 US Taxable (20%)
20%
9.07%
6.27%
$907 / yr
🇬🇧 UK ISA
0%
11.34%
8.54%
$1,134 / yr
🇬🇧 UK Taxable
8.75%
10.35%
7.55%
$1,035 / yr
🇨🇦 TFSA
0%
11.34%
8.54%
$1,134 / yr
🇨🇦 CA Taxable
25%
8.50%
5.70%
$850 / yr
🇦🇺 Super (pension)
15%
9.64%
6.84%
$964 / yr
🇦🇺 AU Taxable
30%
7.94%
5.14%
$794 / yr
🇩🇪 DE Taxable
26.375%
8.35%
5.55%
$835 / yr
🇫🇷 FR Taxable
30%
7.94%
5.14%
$794 / yr
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 OCDX Income Goal & Break-Even
Dividend Break-Even
11yr
Years for dividends to fully repay your OCDX investment of $17.63/share (🇺🇸 US Taxable (15%) · 15.00% tax)
$10K invested · 10 Years
Dividends earned (DRIP)
$14.1K
Lost to inflation (2.8% CPI)
−$2.5K
Real purchasing power gain
$11.6K
12-month CPI (US BLS via FMP economic-indicators).
How much do I need to invest in OCDX for:
Shares needed
14,118
Capital required
$248,900
Monthly income
$2,000
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 OCDX Dividend Payment Schedule
OCDX pays quarterly — 4 times per year. Next ex-div: TBD.
Jan
Feb
Mar
💰
Apr
May
Jun
💰
Jul
Aug
Sep
💰
Oct
Nov
Dec
💰
10 shares
$4.25 / payment
$17.00 / year after tax
100 shares
$42.50 / payment
$170.00 / year after tax
1,000 shares
$425.00 / payment
$1700.00 / year after tax
📊 OCDX vs Healthcare Benchmarks
How OCDX compares to typical Healthcare averages.
Benchmark: Healthcare
Dividend Yield▲+8.54% vs sectorBetter
OCDX
11.34%
avg
2.80%
5Y Dividend CAGR▼-6.80% vs sectorBelow avg
OCDX
0.00%
avg
6.80%
Payout Ratio▲-5.00% vs sectorBetter
OCDX
50.00%
avg
55.00%
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for OCDX sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ OCDX Insider Activity
▼ 1 Sales
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
Insider
Title
Type
Date
Shares
Price
Total Value
Perez David Brian
director
D-Return
2022-05-27
8,576
$7.14
$61.2K
HULL CARL
director
D-Return
2022-05-27
41,172
$7.14
$294.0K
Dilsaver Evelyn S
director
D-Return
2022-05-27
5,200
$7.14
$37.1K
Carlyle Partners VI Cayman Holdings, L.P.
director:
D-Return
2022-05-27
118,106,000
—
—
Carlyle Group Inc.
10 percent owner
D-Return
2022-05-27
118,106,000
$7.14
$843.28M
Carlyle Group Inc.
10 percent owner
Sale
2021-09-14
25,300,000
$16.80
$425.04M
HULL CARL
director
A-Award
2021-05-03
2,600
—
—
Perez David Brian
director
A-Award
2021-05-03
2,600
—
—
Dilsaver Evelyn S
director
A-Award
2021-05-03
5,200
—
—
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
🌍
Geographic Revenue Breakdown
Where OCDX earns its money
UNITED STATES100%
Revenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
📊 About This Data
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the OCDX dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →